Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial | |
Yang Wenying; Liu Jie; Shan Zhongyan; Tian Haoming; Zhou Zhiguang; Ji Qiuhe; Weng Jianping; Jia Weiping; Lu Juming; Liu Jing | |
2014 | |
卷号 | 2期号:1页码:46-55 |
ISSN号 | 2213-8595 |
DOI | 10.1016/S2213-8587(13)70021-4 |
URL标识 | 查看原文 |
收录类别 | PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6671089 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Yang Wenying,Liu Jie,Shan Zhongyan,et al. Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial[J],2014,2(1):46-55. |
APA | Yang Wenying.,Liu Jie.,Shan Zhongyan.,Tian Haoming.,Zhou Zhiguang.,...&Chen Wei.(2014).Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial.,2(1),46-55. |
MLA | Yang Wenying,et al."Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial".2.1(2014):46-55. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论